Angene Chemical
Draw
|
Currency :
Home Products

AG009CEB

1349796-36-6 | XL765

Chemical structure of XL765, CAS 1349796-36-6
AG009CEB
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1349796-36-6
Catalog Number AG009CEB(AGN-PC-088Y6E)
Chemical Name XL765
IUPAC Name N-[4-[[3-(3,5-dimethoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-methylbenzamide
InChI InChI=1S/C31H29N5O6S/c1-19-9-10-20(15-28(19)42-4)31(37)33-21-11-13-25(14-12-21)43(38,39)36-30-29(34-26-7-5-6-8-27(26)35-30)32-22-16-23(40-2)18-24(17-22)41-3/h5-18H,1-4H3,(H,32,34)(H,33,37)(H,35,36)
InChI Key HJSSPYJVWLTYHG-UHFFFAOYSA-N
MDL Number MFCD18252649
Molecular Formula C31H29N5O6S
Molecular Weight 599.6569
SMILES O=C(NC1=CC=C(S(=O)(NC2=NC3=CC=CC=C3N=C2NC4=CC(OC)=CC(OC)=C4)=O)C=C1)C5=CC=C(C)C(OC)=C5
Synonyms
SAR245409, voxtalisib, XL765, XL765, 1349796-36-6, 1123889-87-1, XL-765, PI3K-IN-1, Voxtalisib Analogue, XL 765, XL765 Analogue, SAR245409 (XL765), XL-147 derivative 1, N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide, CHEBI:71958, Voxtalisib (SAR245409, XL765), Voxtalisib (SAR245409, XL765) Analogue, N-[2-[(3,5-Dimethoxyphenyl)amino]quinoxalin-3-yl]-4-[(4-methyl-3-methoxyphenyl)carbonyl]aminophenylsulfonamide, N-[4-[[3-(3,5-dimethoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-methylbenzamide, N-(4-(N-(3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide, CS-0230, MLS006011009, GTPL7964, SCHEMBL8739843, CHEMBL3349370, KS-00001CVG, AOB2912, EX-A234, EX-A278, HMS3654D20, BCP02276, ABP000903, MFCD18252649, s1523, XL765/SAR245409, ZINC70471842, AKOS025401936, RL00494, XL765(SAR245409), NCGC00346541-01, NCGC00346541-08, XL-765, SAR245409, AC-27422, BC600525, DA-45835, HY-12068, SC-95474, SC-95576, SMR004702807, XL-765 (SAR245409), AB0033716, FT-0753985, FT-0761386, SW218114-2, X7418, W-5739, J-006627, J-523311, BRD-K75308783-001-01-3, XL 765, 1123889-87-1, N-[4-({[3-(3,5-Dimethoxyanilino)-2-quinoxalinyl]amino}sulfonyl)phenyl]-3-methoxy-4-methylbenzamide, N-[4-[[[3-[(3,5-dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methyl-benzamide, N-[4-[[[3-[(3,5-dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methyl-benzamide|||SAR-245409, voxtalisib, SAR245409, D01PGR, D05NDW, D0I3KU, cc-497, C31H29N5O6S, CS-230, ACN-029591, SAR-245409, Voxtalisib (XL765, SAR245409), XL-765, SAR245409,, A3941, A5634, A10997, SAR245409/MSC1936369B combination therapy, 934493-76-2, RTK inhibitors (cancer), Shenzhen Chipscreen Biosciences, CS-0230 series (multi receptor tyrosine kinase inhibitors, cancer), CS-0230 series (multi receptor tyrosine kinase inhibitors, cancer), Shenzhen Chipscreen, Pyrido[2,3-d]pyrimidin-7(8H)-one, 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)-, N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited